Active Ingredient: MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE
Proprietary Name: SUFLAVE
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 0.9GM/BOT;178.7GM/BOT;1.12GM/BOT;0.5GM/BOT;7.3GM/BOT
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215344
Product Number: 001
Approval Date: Jun 15, 2023
Applicant Holder Full Name: BRAINTREE LABORATORIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
